| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Beate Lanske | |
| M Shawkat Razzaque | |||
| P2860 | cites work | Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 | Q24290481 |
| FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis | Q24319751 | ||
| Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation | Q24321247 | ||
| Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia | Q24623628 | ||
| Vitamin D. | Q27919675 | ||
| Proximal tubular phosphate reabsorption: molecular mechanisms | Q28140211 | ||
| Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain | Q28141252 | ||
| Dual functional roles of dentin matrix protein 1. Implications in biomineralization and gene transcription by activation of intracellular Ca2+ store | Q28180357 | ||
| Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system | Q28207490 | ||
| Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis | Q28260847 | ||
| Klotho converts canonical FGF receptor into a specific receptor for FGF23 | Q28272505 | ||
| Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice | Q28507303 | ||
| Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo | Q28572995 | ||
| Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities | Q28587985 | ||
| Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism | Q29620323 | ||
| Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23. | Q33264714 | ||
| Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23 | Q34075026 | ||
| FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. | Q54733425 | ||
| DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. | Q54943458 | ||
| Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice | Q56767950 | ||
| Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy | Q57224023 | ||
| Soft tissue calcification in pediatric patients with end-stage renal disease | Q68642526 | ||
| Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis | Q73903058 | ||
| The collagen-specific molecular chaperone HSP47: is there a role in fibrosis? | Q79433884 | ||
| Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease | Q79535578 | ||
| Life-long suppression of growth hormone-insulin-like growth factor I activity in genetically altered rats could prevent age-related renal damage | Q80228977 | ||
| Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice | Q80294165 | ||
| FGF-23, vitamin D and calcification: the unholy triad | Q80394650 | ||
| A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4 | Q82859928 | ||
| Toward a better understanding of Klotho | Q83283214 | ||
| Molecular mechanism of active Ca2+ reabsorption in the distal nephron | Q34112653 | ||
| Disease model: human aging | Q34207950 | ||
| Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older | Q34437473 | ||
| Calcium plus vitamin D supplementation and the risk of fractures | Q34495055 | ||
| Klotho: a fundamental regulator of aging | Q34936976 | ||
| Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals | Q35569891 | ||
| Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. | Q35728669 | ||
| Fibroblast growth factor 23: a phosphatonin regulating phosphate homeostasis? | Q35806103 | ||
| Calcium absorption across epithelia | Q35993306 | ||
| Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter | Q36191092 | ||
| Fibroblast growth factor 23 and its receptors | Q36216951 | ||
| Structural and biochemical properties of fibroblast growth factor 23. | Q36216956 | ||
| Post-translational modification of Fibroblast Growth Factor 23. | Q36216962 | ||
| Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism | Q36216977 | ||
| Expression profiling in the aging brain: a perspective. | Q36297032 | ||
| Aging of mesenchymal stem cells | Q36323407 | ||
| Renal fibrosis: new insights into the pathogenesis and therapeutics | Q36366487 | ||
| Mitochondrial DNA mutations, energy metabolism and apoptosis in aging muscle | Q36463506 | ||
| Vitamin D and calcium receptors: links to hypercalciuria | Q36507233 | ||
| Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism | Q36507256 | ||
| Premature aging in klotho mutant mice: cause or consequence? | Q36757962 | ||
| Vitamin D and aging: old concepts and new insights | Q36832673 | ||
| The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel | Q40359636 | ||
| 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport | Q40397501 | ||
| An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. | Q40482177 | ||
| Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders | Q40530218 | ||
| Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)(2) vitamin D(3). | Q40752367 | ||
| Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. | Q42493065 | ||
| Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process | Q42736434 | ||
| Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population | Q44059496 | ||
| Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia | Q44414604 | ||
| Gains in bone mineral density with resolution of vitamin D intoxication | Q44594307 | ||
| Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis | Q44779387 | ||
| Intracranial calcification and tumoural calcinosis during vitamin D therapy | Q44823843 | ||
| Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders | Q45187805 | ||
| In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions | Q47212064 | ||
| Annual injection of vitamin D and fractures of aged bones. | Q50541730 | ||
| Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. | Q50792778 | ||
| Can renal fibrosis be reversed? | Q52047488 | ||
| Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis. | Q53501998 | ||
| Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. | Q53964449 | ||
| Hypervitaminosis D mediates compensatory Ca2+ hyperabsorption in TRPV5 knockout mice. | Q54644767 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 311-318 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Current Opinion in Nephrology and Hypertension | Q15756282 |
| P1476 | title | Mineral metabolism and aging: the fibroblast growth factor 23 enigma | |
| P478 | volume | 16 |
| Q37459100 | Ageing and vitamin D deficiency: effects on calcium homeostasis and considerations for vitamin D supplementation |
| Q37418420 | Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23 |
| Q35335476 | Checkpoint kinase Chk2 controls renal Cyp27b1 expression, calcitriol formation, and calcium-phosphate metabolism |
| Q27333726 | Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/- mice |
| Q37182735 | Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism? |
| Q28085476 | Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity |
| Q35129687 | FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. |
| Q28473286 | Genetic evidence of serum phosphate-independent functions of FGF-23 on bone |
| Q41032238 | Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization. |
| Q37072412 | In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis |
| Q35507681 | Janus kinase 3 regulates renal 25-hydroxyvitamin D 1α-hydroxylase expression, calcitriol formation, and phosphate metabolism. |
| Q41900414 | Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma? |
| Q35592374 | Links between Vitamin D Deficiency and Cardiovascular Diseases |
| Q35059741 | Osteo-renal regulation of systemic phosphate metabolism |
| Q26860470 | Regulation and function of the FGF23/klotho endocrine pathways |
| Q34479134 | Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease |
| Q39658415 | Synthesis of N-Heteroaroyl Aminosaccharide Derivatives as Fibroblast Growth Factor 2 Signaling Modulators |
| Q36860289 | The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis |
| Q42529430 | Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372 |
Search more.